Patients should have clear instructions on when to seek emergency care and how to contact their provider
In response to growing criticism of the cost of their drugs, Novo Nordisk, the company that manufactures Ozempic and Wegovy, reported last year that rebates and other fees (across all payers) accounted for about 40% of the cost of the two drugs and that they expected rebates to grow
Ongoing care: Youll message your provider for refills and dose adjustments
February 2024 Ozempic, Mounjaro and Other GLP-1 Lawsuit Update The new findings were released within a week of the U.S
You're researching dosing protocols, injection timing, cycling schedules
The MHRA has approved various GLP-1 medications for type 2 diabetes and, more recently, for weight management in specific circumstances